Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q1 2017 · 10-Q
Revenue$3.76M$3.76M+55.4% vs Q1 2016 Net Income-$3.78M-$3.78MN/M vs Q1 2016 EPS Diluted-$0.06-$0.06N/M vs Q1 2016 Gross Profit$2,433,003+49.7% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Operating Cash Flow$25,587N/M Free Cash Flowderived$25,587N/M Margins · derivedGross margin64.6%−2.5 pt vs Q1 2016
Operating margin-97.1%−47.3 pt vs Q1 2016
Net margin-100.5%−37.3 pt vs Q1 2016
ended Mar 31, 2017 · filed May 9, 2017 · 39 d after period end